US · Healthcare

Athira Pharma Inc (ATHA)

Biotechnology

Athira Pharma Inc (ATHA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for ATHA

P/E ratio
18.00

Athira Pharma Inc (ATHA) — FAQ

What is ATHA's P/E ratio?

The price-to-earnings (P/E) ratio for Athira Pharma Inc (ATHA) is 18.00 (data as of 2026-03-23).

Does Athira Pharma Inc pay a dividend?

Dividend yield is not available in the current snapshot for Athira Pharma Inc (ATHA). Check the MyAverix Finance app for the latest dividend data.

What sector is Athira Pharma Inc in?

Athira Pharma Inc (ATHA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATHA listed on?

ATHA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play